Setting new standards in information exchange for the pharmaceutical and biotech industry
2nd Annual Clinical Research as a Care Option (CRAACO) Event Comes to Cambridge, MA in April 2018
January 22, 2018
The Conference Forum will present its second annual Clinical Research as a Care Option (CRAACO) event in Cambridge, MA on April 11, 2018. The program tackles one of the greatest paradigm shifts in clinical research and clinical care by joining them together to give patients the best possible care options. CRAACO is designed to help bring clinical research closer to patients and patients closer to clinical trials.
Co-chair, Katherine Vandebelt, Chief Ecosystem Officer, Reify Health, says, “Arguably, one of the greatest paradigm shifts in clinical research is to make it a care option within the healthcare ecosystem to allow patients to choose the best option.”
Valerie Bowling, Executive Director, the Conference Forum, adds, “We first presented this topic with Eli Lilly, Wilmington Health and PMG Research four years ago at our Disruptive Innovations (DPharm) event. We have been building on that experience ever since with a dedicated group of advisors, and we are thrilled to present the second annual program this April.”
“Higher rates of clinical trial participation inside a health system produce better patient outcomes, lower cost of care and happier patients,” continues Ms. Bowling. “Health systems and patients get access to the latest research, while pharma gets access to more patients in need of clinical research options. This movement is closing the gap between transactional clinical research and integrated clinical care.”
Led by co-chairs Jeff James, CEO, Wilmington Health, and Katherine Vandebelt, Chief Ecosystem Officer, Reify Health, CRAACO opens with a frank discussion about why clinical research is not typically a care option, the barriers, and how to build a path for possibility. Additional sessions include a joint discussion between the healthcare and clinical research ecosystems on how to come together to give patients the best possible care options; a panel on working with medical practices to offer patients clinical trials and establishing physician champions; and a case study from AmericanWell on how telehealth can address challenges of clinical care remotely.
Further discussions address the perspectives of patients and patient advocacy on how we can make patients aware of opportunities for education and engagement; the regulatory and ethical considerations of blurring the lines between clinical research and clinical care; and how we can recruit and train more investigators to make physicians more well versed in clinical research.
The CRAACO advisory board and speaking faculty includes:
- Murray Abramson, MD, VP, Clinical Operations, Biogen
- Alison Bateman-House, MD, Assistant Professor, Division of Medical Ethics, NYU Langone Health
- Jennifer Byrne, Founder, The Greater Gift
- Marcella Debidda, PhD, VP, Patient Engagement, Science 37
- Christopher Dowd, Business Director of Clinical Affairs, Cystic Fibrosis Foundation
- Judy Hung, MD, Director of Trial Innovation Unit, Division of Clinical Research, Massachusetts General Hospital
- Jonathan Jackson, PhD, Director of CARE Research Center, Massachusetts General Hospital
- Jeff James, CEO, Wilmington Health
- Jim Kremidas, Executive Director, Association of Clinical Research Professionals
- Suzanne Nutter, Senior Director, Pharmaceutical Project Management, Eli Lilly
- Tricha Shivas, MBe, Manager of Development, WomenHeart
- John Stewart, MD, Chief of Surgery, Associate Professor of Surgery, Durham Veterans Administration Hospital, Duke University
- Katherine Vandebelt, Chief Ecosystem Officer, Reify Health, Inc
- Kurt Waldhuetter, VP Research Innovation & Business, Aurora Research Institute
Visit our website to learn more about on CRAACO.
About the Conference Forum
The Conference Forum is a life science industry research firm which develops conferences primarily around how to get therapeutics to patients faster. We examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common goals that are patient-focused.